Ruxolitinib for pulmonary extramedullary hematopoiesis in myelofibrosis

MeSH terms

• Aged
• Female
• Follow-Up Studies
• Hematopoiesis, Extramedullary / drug effects*
• Humans
• Janus Kinases / antagonists & inhibitors
• Nitriles
• Primary Myelofibrosis / diagnosis
• Primary Myelofibrosis / drug therapy*
• Primary Myelofibrosis / metabolism
• Primary Myelofibrosis / pathology*
• Protein Kinase Inhibitors / pharmacology
• Protein Kinase Inhibitors / therapeutic use
• Pyrazoles / pharmacology*
• Pyrazoles / therapeutic use*
• Pyrimidines
• Tomography, X-Ray Computed
• Treatment Outcome